Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein
Clinical trial NCT01793818 · UNKNOWN
Trial details
- NCT number
- NCT01793818
- Sponsor
- BIOSANTECH
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.